Privia Health (PRVA) director receives 8,463 restricted stock units as equity award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.

Privia Health Group director Francis S. Soistman Jr. received an equity award in the form of restricted stock units. On May 20, 2026, he was granted 8,463 restricted stock units under the company’s 2021 Omnibus Incentive Plan. These units will vest on the earlier of the day immediately preceding Privia’s 2027 annual stockholders’ meeting or the first anniversary of the grant date. Following this award, his reported direct holding related to this grant is 8,463 shares, reflecting a routine, compensation-based equity grant rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SOISTMAN FRANCIS S JR

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.01 par value per share	8,463	$0.00	--

Holdings After Transaction: Common Stock, $0.01 par value per share — 8,463 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Restricted stock units granted: 8,463 units Price per unit: $0.00 per unit Shares after transaction: 8,463 shares +2 more

5 metrics

Restricted stock units granted 8,463 units Equity award granted May 20, 2026

Price per unit $0.00 per unit Compensation grant, no cash paid

Shares after transaction 8,463 shares Total reported direct holding following grant

Vesting trigger Earlier of 2027 meeting or 1-year Vest before 2027 annual meeting or by first anniversary

Security type Common Stock, $0.01 par value Underlying security for RSU award

Key Terms

restricted stock units, 2021 Omnibus Incentive Plan, vesting, Form 4

4 terms

restricted stock units financial

"the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2021 Omnibus Incentive Plan financial

"received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"

vesting financial

"The restricted stock units will vest on the earlier of the day immediately preceding the Company's 2027 annual meeting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/22/2026 - 08:26 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SOISTMAN FRANCIS S JR

(Last)

(First)

(Middle)

950 N GLEBE RD

SUITE 700

(Street)

ARLINGTON

VIRGINIA

22203

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $0.01 par value per share	05/20/2026		A		8,463⁽¹⁾	A	$0	8,463	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

Remarks:

	/s/ Anita Beth Adams, as attorney-in-fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Privia Health Group (PRVA) report for Francis S. Soistman Jr.?

Privia Health Group reported that director Francis S. Soistman Jr. received 8,463 restricted stock units as an equity award. The grant was made under the company’s 2021 Omnibus Incentive Plan and is classified as an acquisition, not an open-market purchase or sale.

How many shares or units did the Privia Health (PRVA) director acquire in this Form 4?

The director was granted 8,463 restricted stock units tied to Privia Health common stock. These units represent a stock-based compensation award and will convert into shares upon vesting, rather than being purchased for cash in the open market.

When do the newly granted Privia Health (PRVA) restricted stock units vest?

The 8,463 restricted stock units vest on the earlier of two dates. They vest the day immediately before Privia Health’s 2027 annual meeting of stockholders or on the first anniversary of the May 20, 2026 grant date, whichever occurs first.

Is the Privia Health (PRVA) Form 4 transaction a market purchase or sale of shares?

The Form 4 does not report a market purchase or sale. It shows a grant of 8,463 restricted stock units as compensation, with a reported price per unit of $0.00, meaning no cash changed hands in an open-market transaction.

What is the director’s reported Privia Health (PRVA) holding after this Form 4 grant?

After the grant, the filing shows the director with 8,463 shares associated with this equity award. This reflects the full amount of restricted stock units granted on May 20, 2026, with no additional derivative positions disclosed in the filing.

Under which plan were the Privia Health (PRVA) restricted stock units granted?

The 8,463 restricted stock units were granted under Privia Health Group’s 2021 Omnibus Incentive Plan. This plan provides for equity-based compensation to directors and other participants, typically aligning their interests with long-term shareholder value.